TY - JOUR
T1 - Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (Onset 1).
JO - Diabetes Care
PY - 2017/04/11
AU - Russell-Jones D
AU - Bode BW
AU - De Block C
AU - Franek E
AU - Heller SR
AU - Mathieu C
AU - Philis-Tsimikas A
AU - Rose L
AU - Woo VC
AU - č„´sterskov AB
AU - Graungaard T et al
ED -
DO - DOI: 10.2337/dc16-1771
Y2 - 2025/03/17
ER -